Last reviewed · How we verify

D-Penicillamine — Competitive Intelligence Brief

D-Penicillamine (D-Penicillamine) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Heavy metal chelator / immunosuppressant. Area: Rheumatology / Toxicology.

marketed Heavy metal chelator / immunosuppressant Heavy metals (copper, mercury, lead); disulfide bonds in proteins Rheumatology / Toxicology Small molecule Live · refreshed every 30 min

Target snapshot

D-Penicillamine (D-Penicillamine) — Orphalan. D-Penicillamine is a chelating agent that binds to heavy metals and promotes their urinary excretion, while also modulating immune function through reduction of disulfide bonds.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
D-Penicillamine TARGET D-Penicillamine Orphalan marketed Heavy metal chelator / immunosuppressant Heavy metals (copper, mercury, lead); disulfide bonds in proteins

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Heavy metal chelator / immunosuppressant class)

  1. Orphalan · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). D-Penicillamine — Competitive Intelligence Brief. https://druglandscape.com/ci/d-penicillamine. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: